EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease

Nuria Perretta-Tejedor, Karen L Price, Daniyal J Jafree, Gideon Pomeranz, Maria Kolatsi-Joannou, Carlos Martínez-Salgado, David A Long iD, Elisavet Vasilopoulou iD

Physiological Reports · 2024

DOI: 10.14814/phy2.16129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, 2024. Verfasst von Nuria Perretta-Tejedor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Biology and Cancer Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK. Hauptthemen laut MEDLINE: Cytokines, Kidney Glomerulus, Mice, Inbred C57BL. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK, UKRI | Medical Research Council (MRC), Wellcome Trust (WT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiotrophin‐1 (CT‐1), a member of the interleukin (IL)‐6 cytokine family, has renoprotective effects in mouse models of acute kidney disease and tubulointerstitial fibrosis, but its role in glomerular disease is unknown. To address this, we used the mouse model of nephrotoxic nephritis to test the hypothesis that CT‐1 also has a protective role in immune‐mediated glomerular disease. Using immunohistochemistry and analysis of single‐cell RNA‐sequencing data of isolated glomeruli, we demonstrate that CT‐1 is expressed in the glomerulus in male mice, predominantly in parietal epithelial cells and is downregulated in mice with nephrotoxic nephritis. Furthermore, analysis of data from patients revealed that human glomerular disease is also associated with reduced glomerular CT‐1 transcript levels. In male mice with nephrotoxic nephritis and established proteinuria, administration of CT‐1 resulted in reduced albuminuria, prevented podocyte loss, and sustained plasma creatinine, compared with mice administered saline. CT‐1 treatment also reduced fibrosis in the kidney cortex, peri‐glomerular macrophage accumulation and the kidney levels of the pro‐inflammatory mediator complement component 5a. In conclusion, CT‐1 intervention therapy delays the progression of glomerular disease in mice by preserving kidney function and inhibiting renal inflammation and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesKidney GlomerulusMice, Inbred C57BLAnimalsMaleMiceDisease Models, AnimalHumansFibrosisGlomerulonephritis

Stichwörter der Autor:innen

cardiotrophin‐1fibrosisglomerulusinflammation

Substanzen

cardiotrophin 1Cytokines

Autor:innen und Institutionen

  • Developmental Biology and Cancer Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
  • UCL Centre for Kidney and Bladder Health, London, UK.
  • Department of Physiology and Pharmacology, Translational Research on Renal and Cardiovascular Diseases (TRECARD), University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Specialised Foundation Programme in Research, NHS East of England, Cambridge, UK.
  • Comparative Biomedical Sciences, The Royal Veterinary College, London, UK.

ORCID-Profile: David A Long, Elisavet Vasilopoulou

Förderung

  • Kidney Research UK
  • UKRI | Medical Research Council (MRC)
  • Wellcome Trust (WT)
  • Diabetes UK
  • European Renal Association-European Dialysis and Transplant Association (ERA-EDTA)
  • Foulkes Foundation
  • Medical Research Council

Zitieren

APA

Perretta-Tejedor, N., Price, K. L., Jafree, D. J., Pomeranz, G., Kolatsi-Joannou, M., Martínez-Salgado, C., Long, D. A., & Vasilopoulou, E. (2024). Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease. Physiological Reports. https://doi.org/10.14814/phy2.16129

Vancouver

Perretta-Tejedor N, Price KL, Jafree DJ, Pomeranz G, Kolatsi-Joannou M, Martínez-Salgado C, et al. Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease. Physiological Reports. 2024. doi:10.14814/phy2.16129

BibTeX
@article{PerrettaTejedor2024,
  author = {Perretta-Tejedor, Nuria and Price, Karen L and Jafree, Daniyal J and Pomeranz, Gideon and Kolatsi-Joannou, Maria and Martínez-Salgado, Carlos and Long, David A and Vasilopoulou, Elisavet},
  title = {Cardiotrophin‐1 therapy reduces disease severity in a murine model of glomerular disease},
  journal = {Physiological Reports},
  year = {2024},
  doi = {10.14814/phy2.16129}
}
Kostenlos starten →